STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 62 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $51,000 | -61.1% | 10,612 | -13.9% | 0.00% | – |
| Q4 2019 | $131,000 | 0.0% | 12,328 | -1.9% | 0.00% | – |
| Q3 2019 | $131,000 | -24.3% | 12,571 | +16.4% | 0.00% | – |
| Q2 2018 | $173,000 | +7.5% | 10,803 | +2.7% | 0.00% | – |
| Q1 2018 | $161,000 | -4.7% | 10,523 | -3.0% | 0.00% | – |
| Q4 2017 | $169,000 | -29.0% | 10,846 | -34.1% | 0.00% | – |
| Q1 2015 | $238,000 | -13.8% | 16,457 | +1.9% | 0.00% | -100.0% |
| Q4 2014 | $276,000 | – | 16,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 475,200 | $6,877,000 | 3.03% |
| Avoro Capital Advisors LLC | 475,000 | $6,873,000 | 2.64% |
| VHCP Management, LLC | 451,400 | $6,532,000 | 1.50% |
| Sio Capital Management, LLC | 140,000 | $2,026,000 | 1.15% |
| Opus Point Partners Management, LLC | 75,000 | $1,085,000 | 0.91% |
| Eventide Asset Management | 620,200 | $8,974,000 | 0.68% |
| Telemetry Investments, L.L.C. | 55,000 | $796,000 | 0.44% |
| Healthcare Value Capital, LLC | 25,000 | $362,000 | 0.40% |
| TFS CAPITAL LLC | 259,916 | $3,761,000 | 0.37% |
| FARALLON CAPITAL MANAGEMENT LLC | 672,562 | $9,732,000 | 0.14% |